(Q38073540)

28 August 2017

1 reference

title

Molecular mechanisms in the pathogenesis of diabetic nephropathy: an update (English)

1 reference

28 August 2017

0 references

1 reference

Mandeep Kumar Arora

1

1 reference

28 August 2017

Umesh Kumar Singh

series ordinal

2

1 reference

28 August 2017

language of work or name

1 reference

11 January 2013

1 reference

28 August 2017

published in

Vascular Pharmacology

1 reference

28 August 2017

volume

58

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

259-271

1 reference

Signalling pathways of the TNF superfamily: a double-edged sword

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Effects of NADPH oxidase inhibitor in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-beta through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Changes in glomerular perm-selectivity induced by angiotensin II imply podocyte dysfunction and slit diaphragm protein rearrangement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Role of vascular endothelial growth factor in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Role of aldosterone in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Fenofibrate treatment of diabetic rats reduces nitrosative stress, renal cyclooxygenase-2 expression, and enhanced renal prostaglandin release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Peroxisome proliferator-activated receptors: nuclear control of metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Production and physiological actions of anandamide in the vasculature of the rat kidney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Tissue distribution of adenosine receptor mRNAs in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Activation of a local tissue angiotensin system in podocytes by mechanical strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Vasoactive hormones and renal sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Cytokines in autoimmune disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Identification of renox, an NAD(P)H oxidase in kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The renin-angiotensin-aldosterone system, glucose metabolism and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

NADPH oxidases in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Mineralocorticoid Receptor Antagonist Reduces Renal Injury in Rodent Models of Types 1 and 2 Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal--regulated kinase and protein kinase Cdelta activities in human mesangial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The Renal Expression of Transforming Growth Factor- Isoforms and Their Receptors in Acute and Chronic Experimental Diabetes in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Inflammatory cytokines upregulate nephrin expression in human embryonic kidney epithelial cells and podocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-beta in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Transforming growth factor-β and Smads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Reactive oxygen species-regulated signaling pathways in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Role of angiotensin II in diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Adenosine induces a calcium-dependent glomerular contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The protective effect of losartan in the nephropathy of the diabetic rat includes the control of monoamine oxidase type A activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Diabetes induces changes of catecholamines in primary mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Extracellular matrix metabolism in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

(Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Structural-functional relationships in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Inflammation and diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Effect of TNF-alpha inhibition on urinary albumin excretion in experimental diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The role of the kidneys in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Intrarenal angiotensin II and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The role of inflammatory cytokines in diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Adenosine induces mesangial cell contraction by an A1-type receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Specificity, diversity, and regulation in TGF-beta superfamily signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

TPA-induced contraction of isolated rabbit vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The aggravating mechanisms of aldosterone on kidney fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Adenosine mediates transforming growth factor-beta 1 release in kidney glomeruli of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Inhibitory smads and tgf-Beta signaling in glomerular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Molecular mechanisms of hypertension: role of Nox family NADPH oxidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Detection of serum IL-6 in patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

A novel superoxide-producing NAD(P)H oxidase in kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: response to insulin and antioxidant therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Adenosine receptors and signaling in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-beta1-mediated renal fibrosis and dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Suppressing renal NADPH oxidase to treat diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The effect of ruboxistaurin on nephropathy in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Adenosine A(2B) receptor mediates an increase on VEGF-A production in rat kidney glomeruli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Adenosine and kidney function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Role of oxidative stress in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Generation of superoxide from nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The pathophysiology of tumor necrosis factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Gene expression of adenosine receptors along the nephron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Inhibition of the Jak/STAT signaling pathway prevents the high glucose-induced increase in tgf-beta and fibronectin synthesis in mesangial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Transforming growth factor-beta and Smad signalling in kidney diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Peroxynitrite mediates glomerular lesion of diabetic rat via JAK/STAT signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Mesangial cell protein kinase C isozyme activation in the diabetic milieu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Reactive oxygen species, PKC-beta1, and PKC-zeta mediate high-glucose-induced vascular endothelial growth factor expression in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Expression of transforming growth factor-beta isoforms in human glomerular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Rapamycin prevents early steps of the development of diabetic nephropathy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Different expressions of protein kinase C-alpha, beta I and beta II in glomeruli of diabetic nephropathy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Reduced expression of lipoic acid synthase accelerates diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Receptor-dependent prorenin activation and induction of PAI-1 expression in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Intrarenal dopamine inhibits progression of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

The extracellular matrix in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2013.01.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2013.01.001

1 reference

28 August 2017

1 reference